Overview

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Status:
Completed
Trial end date:
2013-06-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and pharmacokinetics of MMX mesalamine following administration in children and adolescents with ulcerative colitis.
Phase:
Phase 1
Details
Lead Sponsor:
Shire
Treatments:
Mesalamine